AU8217787A - Process for the preparation of quinoline carboxylic acids - Google Patents

Process for the preparation of quinoline carboxylic acids

Info

Publication number
AU8217787A
AU8217787A AU82177/87A AU8217787A AU8217787A AU 8217787 A AU8217787 A AU 8217787A AU 82177/87 A AU82177/87 A AU 82177/87A AU 8217787 A AU8217787 A AU 8217787A AU 8217787 A AU8217787 A AU 8217787A
Authority
AU
Australia
Prior art keywords
preparation
carboxylic acids
quinoline carboxylic
agents
esters
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU82177/87A
Other versions
AU593961B2 (en
Inventor
Michael Preiss
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer Healthcare AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare AG filed Critical Bayer Healthcare AG
Publication of AU8217787A publication Critical patent/AU8217787A/en
Application granted granted Critical
Publication of AU593961B2 publication Critical patent/AU593961B2/en
Assigned to BAYER HEALTHCARE AG reassignment BAYER HEALTHCARE AG Alteration of Name(s) in Register under S187 Assignors: BAYER AKTIENGESELLSCHAFT
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

A process for the preparation of quinolinecarboxylic acids of the formula (I) <IMAGE> in which R<1>, R<2> and R<3>, X and A have the meaning given in the description, which are used as such or in the form of their esters, salts, prodrugs etc. as antibacterial agents in human and veterinary medicine and as agents stimulating the immune defence.
AU82177/87A 1986-12-03 1987-12-03 Process for the preparation of quinoline carboxylic acids Expired AU593961B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19863641312 DE3641312A1 (en) 1986-12-03 1986-12-03 METHOD FOR PRODUCING CHINOLINE CARBONIC ACIDS
DE3641312 1986-12-03

Publications (2)

Publication Number Publication Date
AU8217787A true AU8217787A (en) 1988-06-09
AU593961B2 AU593961B2 (en) 1990-02-22

Family

ID=6315377

Family Applications (1)

Application Number Title Priority Date Filing Date
AU82177/87A Expired AU593961B2 (en) 1986-12-03 1987-12-03 Process for the preparation of quinoline carboxylic acids

Country Status (25)

Country Link
EP (1) EP0274033B1 (en)
JP (1) JPS63145268A (en)
KR (1) KR970005191B1 (en)
CN (1) CN87107230A (en)
AT (1) ATE73446T1 (en)
AU (1) AU593961B2 (en)
CS (1) CS270577B2 (en)
DD (1) DD270904A5 (en)
DE (2) DE3641312A1 (en)
DK (1) DK174929B1 (en)
ES (1) ES2038156T3 (en)
FI (1) FI875289A (en)
GR (1) GR3004301T3 (en)
HU (1) HU199823B (en)
IE (1) IE64261B1 (en)
IL (1) IL84627A (en)
NO (1) NO174199C (en)
NZ (1) NZ222736A (en)
PH (1) PH24489A (en)
PL (1) PL158614B1 (en)
PT (1) PT86252B (en)
SU (1) SU1482526A3 (en)
UA (1) UA8017A1 (en)
YU (1) YU45049B (en)
ZA (1) ZA879040B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU603352B2 (en) * 1986-02-25 1990-11-15 Otsuka Pharmaceutical Co., Ltd. Benzoheterocyclic compounds

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN166416B (en) * 1985-09-18 1990-05-05 Pfizer
EP0470252A4 (en) * 1989-04-28 1992-12-02 Daiichi Pharmaceutical Co., Ltd. Anti-hiv drug
US5385913A (en) * 1989-10-06 1995-01-31 Pfizer Inc. 1,4-dihydro-4-oxo-3-quinoline derivatives as selectively toxic mammalian antibacterial agents
WO1991004972A1 (en) * 1989-10-06 1991-04-18 Pfizer Inc. 1,4-dihydro-4-oxo-3-quinoline derivatives as selectively toxic mammalian antibacterial agents
JP2613139B2 (en) * 1990-07-19 1997-05-21 エスエス製薬 株式会社 Quinolonecarboxylic acid derivatives
ES2050613B1 (en) * 1992-10-16 1996-03-16 Iteve S A NEW PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF THE ACID 1-CICLOPROPIL-3-QUINOLINCARBOXILICO.
US6034100A (en) * 1993-03-10 2000-03-07 Otsuka Pharmaceutical Co., Ltd. Method for inhibiting cytokine secretion
AU6421898A (en) * 1997-03-25 1998-10-20 Sankyo Company Limited Anti-fiv agent
KR100454750B1 (en) * 2002-06-20 2004-11-03 삼성에스디아이 주식회사 Blue light-emitting compound for organic electroluminescent device and organic electroluminescent device using the same
BRPI0413964B8 (en) 2003-09-10 2021-05-25 Kyorin Seiyaku Kk quinolone carboxylic acid derivative acid, its composition and antibacterial agent
JP5322927B2 (en) 2007-05-24 2013-10-23 杏林製薬株式会社 A mutilin derivative having a heteroaromatic carboxylic acid structure at the 14-position substituent.
CN101671302B (en) * 2008-12-30 2011-03-30 广东海康兽药有限公司 Production process of enrofloxacin antibacterial drug for fowl and livestock
CN101899044B (en) * 2010-08-16 2012-07-18 常州市勇毅生物药业有限公司 Method for synthesizing Gemifloxacin main ring compound
CN113912540A (en) * 2021-12-15 2022-01-11 山东国邦药业有限公司 Synthesis method of 1-cyclopropyl-6, 7-difluoro-1, 4-dihydro-4-oxo-3-quinolinecarboxylic acid

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5365887A (en) * 1976-11-22 1978-06-12 Kyorin Seiyaku Kk Substituted quinoline*arboxylate and process for preparing same
DE2656574A1 (en) * 1976-12-10 1978-06-15 Schering Ag 1-Alkyl-4-oxo-1,4-di:hydro-1,6-naphthyridine-3-carboxylic acid derivs. - with antibacterial activity esp. effective in the urinary tract
JPS53141286A (en) * 1977-05-16 1978-12-08 Kyorin Seiyaku Kk Novel substituted quinolinecarboxylic acid
JPS5845426B2 (en) * 1978-09-29 1983-10-08 杏林製薬株式会社 Substituted quinoline carboxylic acid derivatives
DE3142854A1 (en) * 1981-10-29 1983-05-11 Bayer Ag, 5090 Leverkusen 1-CYCLOPROPYL-6-FLUOR-1,4-DIHYDRO-4-OXO-7-PIPERAZINO-CHINOLINE-3-CARBONIC ACIDS, METHOD FOR THE PRODUCTION THEREOF AND THEIR CONTAINING ANTIBACTERIAL AGENTS
DE3318145A1 (en) * 1983-05-18 1984-11-22 Bayer Ag, 5090 Leverkusen 7-AMINO-1-CYCLOPROPYL-6,8-DIFLUOR-1,4-DIHYDRO-4-OXO-3-CHINOLINE CARBONIC ACIDS, METHOD FOR THE PRODUCTION THEREOF AND THEIR CONTAINING ANTIBACTERIAL AGENTS
AU553415B2 (en) * 1983-09-19 1986-07-17 Abbott Japan Co., Ltd. 6-fluoro-1-4-dihydro-4-oxo-7-substituted piperazinyl- quinoline-3-carboxylic acids
IL74244A (en) * 1984-02-17 1988-06-30 Warner Lambert Co Quinoline derivatives,their preparation and pharmaceutical compositions containing them
DE3420743A1 (en) * 1984-06-04 1985-12-05 Bayer Ag, 5090 Leverkusen 7-AMINO-1-CYCLOPROPYL-6,8-DIHALOGEN-1,4-DIHYDRO-4-OXO-3-CHINOLINE CARBONIC ACIDS, METHOD FOR THE PRODUCTION THEREOF AND THEIR CONTAINING ANTIBACTERIAL AGENTS
JPS61205258A (en) * 1985-03-08 1986-09-11 Kyorin Pharmaceut Co Ltd Quinolonecarboxylic acid derivative and production thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU603352B2 (en) * 1986-02-25 1990-11-15 Otsuka Pharmaceutical Co., Ltd. Benzoheterocyclic compounds

Also Published As

Publication number Publication date
JPS63145268A (en) 1988-06-17
PH24489A (en) 1990-07-18
KR880007472A (en) 1988-08-27
UA8017A1 (en) 1995-12-26
NO174199B (en) 1993-12-20
FI875289A0 (en) 1987-12-01
ATE73446T1 (en) 1992-03-15
DK633187D0 (en) 1987-12-02
DK174929B1 (en) 2004-03-01
DE3777370D1 (en) 1992-04-16
DK633187A (en) 1988-06-04
CN87107230A (en) 1988-07-06
NZ222736A (en) 1990-08-28
PT86252B (en) 1990-11-07
DD270904A5 (en) 1989-08-16
IE873279L (en) 1988-06-03
NO874788D0 (en) 1987-11-17
PL269185A1 (en) 1989-01-05
IL84627A (en) 1992-01-15
CS868887A2 (en) 1989-11-14
NO174199C (en) 1994-04-06
PL158614B1 (en) 1992-09-30
ZA879040B (en) 1988-05-26
IE64261B1 (en) 1995-07-26
EP0274033B1 (en) 1992-03-11
NO874788L (en) 1988-06-06
YU45049B (en) 1991-06-30
SU1482526A3 (en) 1989-05-23
EP0274033A1 (en) 1988-07-13
ES2038156T3 (en) 1993-07-16
CS270577B2 (en) 1990-07-12
HU199823B (en) 1990-03-28
HUT45521A (en) 1988-07-28
KR970005191B1 (en) 1997-04-14
YU215687A (en) 1988-10-31
IL84627A0 (en) 1988-04-29
FI875289A (en) 1988-06-04
PT86252A (en) 1988-01-01
DE3641312A1 (en) 1988-06-09
AU593961B2 (en) 1990-02-22
GR3004301T3 (en) 1993-03-31

Similar Documents

Publication Publication Date Title
AU8217787A (en) Process for the preparation of quinoline carboxylic acids
NZ227680A (en) Quinoline and naphthyridine derivatives, intermediates and pharmaceutical compositions
EP0422485A3 (en) Quinolone carboxylic acid derivatives, process for their preparation and their use
EP0287926A3 (en) Process for the preparation of quinoline carboxylic acids for parenteral application
EP0255908A3 (en) 7-ûû3-(aminomethyl)-3-alkyl¨-1-pyrrolidinyl¨-quinoline-carboxylic acid-derivatives and pharmaceutical compositions containing them
KR0148213B1 (en) Phenyla lkan(en)oic acid and pharmaceutical composition comprising the same
GR3002679T3 (en) Dihydropyridinamides, process for their preparation and their use in medicines
HU912169D0 (en) Process for the production of 3,3&#39;-ditio-bis(propionic acid)-derivatives and esthers, and medical preparations containing them
AU638437B2 (en) Substituted azetidinylpyridonecarboxylic acid derivatives, their preparation and their application as medicinal products
HK1006713A1 (en) Acylsulphonamido and sulphonamidopyridine-2-carboxylic acid esters pyridine-n-oxides thereof a process for their preparation and their use as medicaments
GR3019381T3 (en) 3-Anilino-2-hydroxycarbonyl-4-thiophen-acetic acids
GR3022259T3 (en) Tetrahydro-4-phenylimino-3-thiophen-acetic acids

Legal Events

Date Code Title Description
PC Assignment registered

Owner name: BAYER HEALTHCARE AG

Free format text: FORMER OWNER WAS: BAYER AKTIENGESELLSCHAFT